important day today ... if there is not much damage to the sp i think we will be ok. small damage will suggest that the market is pricing this in.The project is robust and is still on track will still fly as we run into production imho
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%